News
-
‘We are going to have to be agile’: Butler
- Fri Sep 18
Desperate to fill the pending gap left by AZ’s Zoladex leaving the PBS, the government demonstrates how fast it can move when patient access is threatened.
Read more -
A thousand opinions, zero insights
- Fri Sep 18
OP-ED: Use of consumer surveys for media releases can be lazy public relations, not telling journalists anything other than the bleeding obvious.
Read more -
Roadmap aims to prevent repeat heart attacks
- Fri Sep 18
New expert roadmap targets post‑hospital care gaps to reduce repeat heart attacks across Queensland.
Read more -
MA picks up another new member
- Wed Sep 16
In arguably one of the biggest growth periods in Medicines Australia’s history, another big name pharma has returned after a six year hiatus.
Read more -
PBAC risks falling behind global HTA peers
- Wed Sep 16
Researchers compared PBAC to nine other leading HTA agencies, noting where Australia’s HTA agency stands out, and where it lags behind.
Read more -
Four female leaders make big career moves
- Wed Sep 16
Four senior executive women have announced significant moves in their careers, including a former Aussie pharma MD and a senior NSW bureaucrat.
Read more -
GPs hold the key to clinical trial access
- Wed Sep 16
Most Australians are willing to join clinical trials but few hear about them from their GP, new Sanofi research finds.
Read more -
Lights, camera, nominate: Hollywood enters Board race
- Mon Sep 14
Boehringer’s Ed Hollywood on why he’s standing for the MA Board and his ‘uncomfortable’ proposal for delivering better access to medicines.
Read more